CoG - Hybrid Glucometer

Meet The World’s First Hybrid, Non-Invasive Glucometer

Medically Tested & Clinicly Proven.

CE Approved. FDA Pending

Trusted & Loved by Top Industry Experts

​

“… I must conclude that this is the most accurate performance of a non-invasive device technology for prediction of blood glucose that I have seen so far. In fact, this device represents a major improvement in non-invasive glucose prediction technologies!”. 

​

Prof. Andreas Pfützner, M.D.,Ph.D

From The Press

Read What Others Think About Us
Putting a fingure in testing device
New fingerprick-free glucose meter takes the “Ouch!” out of diabetes care

Today marks World Diabetes Day, a date chosen in tribute to Dr. Frederick Banting, co-discoverer of insulin, who was born on November 14, 1891.  While the discovery of insulin made survival with diabetes possible, the disease itself continues to spiral out of control around the world…

doing Glucose test and a plate having food in it
To Mark World Diabetes Day, Israeli Company Promotes Needle-Free Glucose Test

Today marks World Diabetes Day, a date chosen in tribute to Dr. Frederick Banting, co-discoverer of insulin, who was born on November 14, 1891.  While the discovery of insulin made survival with diabetes possible, the disease itself continues to spiral out of control around the world.

Holding a bag of blood
Ein Start-up aus Caesarea hat ein Gerät zur schmerzfreien Überprüfung des Blutzuckers entwickelt

Ein Diabetiker muss sich vier- bis fünfmal in den Finger stechen – jeden Tag, sein Leben lang. Mit dem Tropfen Blut misst er seinen Blutzuckerspiegel, um die nötige Menge des Insulins zu bestimmen. »Das sind oft mehr als 100.000-mal Schmerzen und Verletzungen«, sagt Andreas Pfützner vom »Pfützner Science und Health Institut« 

The Future Is Finally Here.

Measure Instantly. Anytime, Anywhere. Up to 90% Less Pricking.

Hybrid Non-invasive & Invasive device

Instant glucose and HbA1c measurement

A personalized device that constantly adjusts to your lifestyle

Better tracking of lifestyle factors can impact glucose level trends

Clinicly tested and CE approved

What Customers Say.

"... A few months ago, I have acquired the CoG device. At the beginning I had some problems with the device, but the company replaced it with a new one and it has been working wonderfully since. I monitor myself about 8 times a day and most of the time over 90% of my readings were pure non-invasive. When I started my HbA1c was 7.5%, a parameter the device also provides as an additional indication. After a few months of use, I started to improve my diet as I saw exactly what kind of food influenced my glucose level. Now my HbA1c is 6.2%. I compared my measurements at the hospital and it was 6.15%, which is amazing! "

​

Maria K. - Germany

attending a covid meeting.jpg

Get Your CoG Now & Stop the Constant Pricking Routine.

Please beware of counterfeit CNOGA Medical products from any other unauthorized websites!

How Does It Work?

Learn How The Magic Happens

1. What is the accuracy of the COG device?

In clinics accuracy Over 3500 non-invasive measurements were compared against the golden standard reference device (YSI)

  1. MARD of 14-17%
  2. 75% of the total non-invasive measurements are within 20% ARD (Absolute Relative Difference)
Usability study at home
  • Over 18,610 non-invasive readings at home during 12 weeks use test
HbA1C HbA1C indicates an approximation of three months’ average percentage of connected glucose to Hemoglobin. It is recommended to reduce these values towards normal level. Nonetheless, it is not guaranteed that normal values indicate a normal situation. As one may be at hyperglycemia and hypoglycemia with normal HbA1C. Therefore, it is important for each one to have a better understanding of his personal glucose pattern.
  • Mean Absolute Relative Diff (MARD)
  • Mean Positive Relative Difference (MPRD)
  • Mean Negative Relative Difference (MNRD)
9.67% 2.18% -7.49%



2. How frequently should I measure my glucose level?

We recommend measuring 8 times a day, nonetheless, one may adopt the schedule that suits his/her lifestyle.



3. I am using Insulin; can I adjust my treatment according to the non-invasive results?

An invasive measurement should be performed prior to taking any medication.



4. What is the calibration process?

The CoG device is composed of two module units: an Add-On module for the quantitative measurement of capillary whole blood samples using test strips similar to any ordinary glucometer and a component for the Non – invasive glucose measurement. The Non – invasive module “learns” the user’s unique glucose pattern by a process called calibration. Calibration is achieved by a combination of invasive reading with test strips and non-invasive reading. The calibration measurements should be performed at different times of the day such as:

  • Upon waking
  • Before breakfast
  • 1-2 hours after breakfast
  • Before lunch
  • 1-2 hours after lunch
  • Before dinner
  • 1-2 hours after dinner
  • Before going to sleep



5. What happens after the calibration ends? Can I start using the device non-invasively?

The device will provide non-invasive results. The device performance can be continuously improved by adding invasive measurements. The device will ask for invasive measurements on the following cases:

  1. The non-invasive measurement result is out of the calibration range.
  2. When the image acquired is unclear (low blood flow to the finger, dirty finger, dirty lens, etc).
  3. When the non-invasive result does not fit with the user’s usual glucose pattern.
  4. Nonetheless, at any time the user can initiate an invasive measurement.



6. How many measurements can I preform in a day?

The device is designed for the purpose of enhancing frequent assessment of blood glucose. Therefore, it is recommended to take measurements as frequently as possible throughout each day. Frequent measurements may assist in improving the management of glucose levels, which are influenced by exercise, food, mood, etc.



7. After the calibration process, what is the frequency of the invasive measurements? Is it necessary to carry all the complementary equipment (lancet device and strips) every day?

The number of invasive measurements may vary between users according to their diabetic severity. Adding invasive measurements will assist the device to learn more about physiological changes, therefore, carrying the complementary equipment is not necessary but might be essential.



8. Is there a need for an additional invasive glucometer?

No, the device has an add-on component that acts as an invasive glucometer, allowing you to use the CoG as a non-invasive and invasive glucometer.



9. How to perform a measurement after calibration?

  • Insert the finger into the finger chamber – reading will be shown on the screen associated with a blue graph and blinking yellow hand. The reading is completed once the graph is changing into a green graph. At this point, remove finger from the finger chamber.

  • In case the device can’t generate a final non-invasive result the user would be asked to insert a strip.

    • If the invasive and non-invasive results are sufficiently close the outcome will be registered in history without concluding post calibration.

    • If the results of the non-invasive and invasive measurements do not agree, the invasive reading will be, by default, the only one that will be presented.

10. HbA1c– what is it?

The term HbA1C refers to glycated hemoglobin. It develops when hemoglobin, a protein within red blood cells that carries oxygen throughout your body, joins with glucose in the blood, becoming ‘glycated’. By measuring glycated hemoglobin (HbA1C), clinicians are able to get an overall picture of what our average blood sugar levels have been over a period of weeks/months. For people with diabetes, this is important as the higher the HbA1c, the greater the risk of developing diabetes-related complications. HbA1C is also referred to as hemoglobin A1c or simply A1c.



FAQ

1. What is the accuracy of the COG device?

In clinics accuracy Over 3500 non-invasive measurements were compared against the golden standard reference device (YSI)

  1. MARD of 14-17%
  2. 75% of the total non-invasive measurements are within 20% ARD (Absolute Relative Difference)
Usability study at home
  • Over 18,610 non-invasive readings at home during 12 weeks use test
HbA1C HbA1C indicates an approximation of three months’ average percentage of connected glucose to Hemoglobin. It is recommended to reduce these values towards normal level. Nonetheless, it is not guaranteed that normal values indicate a normal situation. As one may be at hyperglycemia and hypoglycemia with normal HbA1C. Therefore, it is important for each one to have a better understanding of his personal glucose pattern.
  • Mean Absolute Relative Diff (MARD)
  • Mean Positive Relative Difference (MPRD)
  • Mean Negative Relative Difference (MNRD)
9.67% 2.18% -7.49%



2. How frequently should I measure my glucose level?

We recommend measuring 8 times a day, nonetheless, one may adopt the schedule that suits his/her lifestyle.



3. I am using Insulin; can I adjust my treatment according to the non-invasive results?

An invasive measurement should be performed prior to taking any medication.



4. What is the calibration process?

The CoG device is composed of two module units: an Add-On module for the quantitative measurement of capillary whole blood samples using test strips similar to any ordinary glucometer and a component for the Non – invasive glucose measurement. The Non – invasive module “learns” the user’s unique glucose pattern by a process called calibration. Calibration is achieved by a combination of invasive reading with test strips and non-invasive reading. The calibration measurements should be performed at different times of the day such as:

  • Upon waking
  • Before breakfast
  • 1-2 hours after breakfast
  • Before lunch
  • 1-2 hours after lunch
  • Before dinner
  • 1-2 hours after dinner
  • Before going to sleep



5. What happens after the calibration ends? Can I start using the device non-invasively?

The device will provide non-invasive results. The device performance can be continuously improved by adding invasive measurements. The device will ask for invasive measurements on the following cases:

  1. The non-invasive measurement result is out of the calibration range.
  2. When the image acquired is unclear (low blood flow to the finger, dirty finger, dirty lens, etc).
  3. When the non-invasive result does not fit with the user’s usual glucose pattern.
  4. Nonetheless, at any time the user can initiate an invasive measurement.



6. How many measurements can I preform in a day?

The device is designed for the purpose of enhancing frequent assessment of blood glucose. Therefore, it is recommended to take measurements as frequently as possible throughout each day. Frequent measurements may assist in improving the management of glucose levels, which are influenced by exercise, food, mood, etc.



7. After the calibration process, what is the frequency of the invasive measurements? Is it necessary to carry all the complementary equipment (lancet device and strips) every day?

The number of invasive measurements may vary between users according to their diabetic severity. Adding invasive measurements will assist the device to learn more about physiological changes, therefore, carrying the complementary equipment is not necessary but might be essential.



8. Is there a need for an additional invasive glucometer?

No, the device has an add-on component that acts as an invasive glucometer, allowing you to use the CoG as a non-invasive and invasive glucometer.



9. How to perform a measurement after calibration?

  • Insert the finger into the finger chamber – reading will be shown on the screen associated with a blue graph and blinking yellow hand. The reading is completed once the graph is changing into a green graph. At this point, remove finger from the finger chamber.

  • In case the device can’t generate a final non-invasive result the user would be asked to insert a strip.

    • If the invasive and non-invasive results are sufficiently close the outcome will be registered in history without concluding post calibration.

    • If the results of the non-invasive and invasive measurements do not agree, the invasive reading will be, by default, the only one that will be presented.

10. HbA1c– what is it?

The term HbA1C refers to glycated hemoglobin. It develops when hemoglobin, a protein within red blood cells that carries oxygen throughout your body, joins with glucose in the blood, becoming ‘glycated’. By measuring glycated hemoglobin (HbA1C), clinicians are able to get an overall picture of what our average blood sugar levels have been over a period of weeks/months. For people with diabetes, this is important as the higher the HbA1c, the greater the risk of developing diabetes-related complications. HbA1C is also referred to as hemoglobin A1c or simply A1c.